Literature DB >> 33069987

Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.

Pei Li Fan1, Hong Ding1, Feng Mao1, Ling Li Chen2, Yi Dong1, Wen Ping Wang3.   

Abstract

PURPOSE: To analyze the correlation between enhancement patterns of small hepatic carcinomas (HCCs; ≤ 30 mm) on contrast-enhanced ultrasound (CEUS) and the clinicopathologic characteristics.
METHODS: The retrospective study included 346 inpatients (288 males and 58 females) with 372 pathologically confirmed small HCCs between January 2017 and December 2018. All patients underwent CEUS examination before pathological examination. Statistical analysis was used to determine the correlation between enhancement patterns of small HCCs on CEUS and clinicopathologic characteristics including serum alpha-feto-protein level, protein induced by vitamin K absence or antagonist-II (PIVKA-II) level, primary or recurrent HCC condition, tumor number, tumor differentiation, tumor size, liver background and microvascular invasion (MVI).
RESULTS: Three hundred forty-seven out of 372 (93.3 %) HCCs manifested arterial phase hyper-enhancement (APHE). The arterial enhancement patterns were correlated with the tumor differentiation (odds ratio = 10.336, P = 0.000). Moderately- or poorly-differentiated HCCs were more likely to display APHE than well-differentiated HCCs (96.2 % vs 58.6 %, P < 0.001). Two hundred ninety-five of 372 (79.3 %) HCCs showed washout in the portal venous/late phase. Washout was correlated with serum PIVKA-II level, tumor size, tumor differentiation, and MVI on univariate analysis (P < 0.05). Logistic regression analysis revealed that only tumor size was significantly associated with washout of small HCCs (odds ratio = 2.335, P = 0.006). Large HCCs (20-30 mm) displayed a higher proportion of washout compared with that of HCCs ≤ 20 mm.
CONCLUSIONS: Enhancement patterns of small HCCs on CEUS were significantly correlated with tumor size and tumor differentiation among all clinicopathologic characteristics.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contrast agent; Hepatocellular carcinoma; Ultrasonography

Mesh:

Substances:

Year:  2020        PMID: 33069987     DOI: 10.1016/j.ejrad.2020.109341

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Preoperative Prediction of Microvascular Invasion in Patients With Hepatocellular Carcinoma Based on Radiomics Nomogram Using Contrast-Enhanced Ultrasound.

Authors:  Di Zhang; Qi Wei; Ge-Ge Wu; Xian-Ya Zhang; Wen-Wu Lu; Wen-Zhi Lv; Jin-Tang Liao; Xin-Wu Cui; Xue-Jun Ni; Christoph F Dietrich
Journal:  Front Oncol       Date:  2021-09-07       Impact factor: 6.244

Review 2.  Current Imaging Diagnosis of Hepatocellular Carcinoma.

Authors:  Evangelos Chartampilas; Vasileios Rafailidis; Vivian Georgopoulou; Georgios Kalarakis; Adam Hatzidakis; Panos Prassopoulos
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

3.  Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics.

Authors:  Hui Zhang; Fanding Huo
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

4.  A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Hang Zhou; Jiawei Sun; Tao Jiang; Jiaqi Wu; Qunying Li; Chao Zhang; Ying Zhang; Jing Cao; Yu Sun; Yifan Jiang; Yajing Liu; Xianli Zhou; Pintong Huang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.